Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma

S. Derks; K.S. Nason; X.Y. Liao; M.D. Stachler; K.X. Liu; J. Liu; E. Sicinska; M.S. Goldberg; G.J. Freeman; S.J. Rodig; J.M. Davison; A.J. Bass

doi:10.1158/2326-6066.CIR-15-0046

Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma

S. Derks
, K.S. Nason
, X.Y. Liao
, M.D. Stachler
, K.X. Liu
, J. Liu
, E. Sicinska
, M.S. Goldberg
, G.J. Freeman
, S.J. Rodig
, J.M. Davison
, A.J. Bass

Affiliatie VU

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1123-1129
Journal	Cancer immunology research
Volume	3
Issue number	10
DOIs	https://doi.org/10.1158/2326-6066.CIR-15-0046
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1158/2326-6066.CIR-15-0046

Cite this

@article{514086b1425d49fb8f02598a35d61c0a,

title = "Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma",

author = "S. Derks and K.S. Nason and X.Y. Liao and M.D. Stachler and K.X. Liu and J. Liu and E. Sicinska and M.S. Goldberg and G.J. Freeman and S.J. Rodig and J.M. Davison and A.J. Bass",

year = "2015",

doi = "10.1158/2326-6066.CIR-15-0046",

language = "Undefined/Unknown",

volume = "3",

pages = "1123--1129",

journal = "Cancer immunology research",

issn = "2326-6066",

publisher = "American Association for Cancer Research Inc.",

number = "10",

}

TY - JOUR

T1 - Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma

AU - Derks, S.

AU - Nason, K.S.

AU - Liao, X.Y.

AU - Stachler, M.D.

AU - Liu, K.X.

AU - Liu, J.

AU - Sicinska, E.

AU - Goldberg, M.S.

AU - Freeman, G.J.

AU - Rodig, S.J.

AU - Davison, J.M.

AU - Bass, A.J.

PY - 2015

Y1 - 2015

U2 - 10.1158/2326-6066.CIR-15-0046

DO - 10.1158/2326-6066.CIR-15-0046

M3 - Article

C2 - 26081225

SN - 2326-6066

VL - 3

SP - 1123

EP - 1129

JO - Cancer immunology research

JF - Cancer immunology research

IS - 10

ER -